Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer.

about

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer.

Item

http://www.wikidata.org/entity/Q54967274

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Epigenetic silencing of miR-20 ...... resistance in bladder cancer.

@en

Epigenetic silencing of miR-20 ...... resistance in bladder cancer.

@nl

type

Item

label

Epigenetic silencing of miR-20 ...... resistance in bladder cancer.

@en

Epigenetic silencing of miR-20 ...... resistance in bladder cancer.

@nl

prefLabel

Epigenetic silencing of miR-20 ...... resistance in bladder cancer.

@en

Epigenetic silencing of miR-20 ...... resistance in bladder cancer.

@nl

P1476

Epigenetic silencing of miR-20 ...... resistance in bladder cancer.

@en

P2093

Hiromu Suzuki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kitajima

http://www.w3.org/2001/XMLSchema#string

Masahiro Kai

http://www.w3.org/2001/XMLSchema#string

Naotaka Nishiyama

http://www.w3.org/2001/XMLSchema#string

Naoya Masumori

http://www.w3.org/2001/XMLSchema#string

Nobuo Shinkai

http://www.w3.org/2001/XMLSchema#string

Reo Maruyama

http://www.w3.org/2001/XMLSchema#string

Takashi Tokino

http://www.w3.org/2001/XMLSchema#string

Takeshi Niinuma

http://www.w3.org/2001/XMLSchema#string

Tetsuya Shindo

http://www.w3.org/2001/XMLSchema#string

P2860

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

Global cancer statistics, 2012

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Comprehensive molecular characterization of urothelial bladder carcinoma

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling

Distinct microRNA alterations characterize high- and low-grade bladder cancer

P304

24457-24469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25326

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29849953

http://www.w3.org/2001/XMLSchema#string

P932

5966259

http://www.w3.org/2001/XMLSchema#string